Information Journal Paper
APA:
CopyUCER, OKTAY, CAN ALBAZ, ALI, ATAG, ELIF, KARAOGLU, AZIZ, & MUEZZINOGLU, TALHA. (2016). THE RATE OF NEOADJUVANT CHEMOTHERAPY USE IN MUSCLE INVASIVE BLADDER CANCER AND THE APPROACH OF UROLOGISTS IN TURKEY. UROLOGY JOURNAL, 13(5), 2841-2844. SID. https://sid.ir/paper/271186/en
Vancouver:
CopyUCER OKTAY, CAN ALBAZ ALI, ATAG ELIF, KARAOGLU AZIZ, MUEZZINOGLU TALHA. THE RATE OF NEOADJUVANT CHEMOTHERAPY USE IN MUSCLE INVASIVE BLADDER CANCER AND THE APPROACH OF UROLOGISTS IN TURKEY. UROLOGY JOURNAL[Internet]. 2016;13(5):2841-2844. Available from: https://sid.ir/paper/271186/en
IEEE:
CopyOKTAY UCER, ALI CAN ALBAZ, ELIF ATAG, AZIZ KARAOGLU, and TALHA MUEZZINOGLU, “THE RATE OF NEOADJUVANT CHEMOTHERAPY USE IN MUSCLE INVASIVE BLADDER CANCER AND THE APPROACH OF UROLOGISTS IN TURKEY,” UROLOGY JOURNAL, vol. 13, no. 5, pp. 2841–2844, 2016, [Online]. Available: https://sid.ir/paper/271186/en